Skip to content
The Nexus
DossierENTITY

Likang Life Sciences

Coverage of Likang Life Sciences in the Nexus archive.

Earliest in view: Jun 29 · 03:00 UTCMost recent: Jun 29 · 03:00 UTC
Co-mentioned in this coverage
Chinaplace2Beijing Economic and Technological Development Zoneplace2cancertopic2AI-assisted personalised tumour vaccinestopic1AI-powered cancer vaccine production linetopic1personalized tumor vaccinestopic1
Recent coverage
  • HEALTHJun 29 · 03:00 UTCSCMP WORLD
    China’s first AI-powered cancer vaccine production line set to launch in Beijing

    China is launching its first AI-powered production line for personalized cancer vaccines, developed by Beijing-based Likang Life Sciences. The company plans to complete a new drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October, with a 110 million yuan investment.

  • HEALTHJun 29 · 03:00 UTCSCMP CHINA
    China’s first AI-powered cancer vaccine production line set to launch in Beijing

    China is developing its first AI-assisted personalized tumor vaccine production line, with Beijing-based Likang Life Sciences set to complete a drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October. The project, backed by a 110 million yuan investment, aims to address cancer, the nation's second-leading cause of death.